Moderna (MRNA) Reports $472M Expansion of BARDA Agreement to Support Larger Phase 3 Program for Vaccine (mRNA-1273) Against COVID-19

Go back to Moderna (MRNA) Reports $472M Expansion of BARDA Agreement to Support Larger Phase 3 Program for Vaccine (mRNA-1273) Against COVID-19
Marina Biotech, Inc. (NASDAQ: MRNA) Delayed: 172.94 +18.90 (12.27%)
Previous Close $154.04    52 Week High $0.52 
Open $161.05    52 Week Low $0.08 
Day High $176.86    P/E N/A 
Day Low $159.06    EPS $-3.80 
Volume 20,977,866